Anecortave Acetate

乙酸阿奈可他

Report date: 2025/12/01 11:11:08
NME

Base Information

Drug NameAnecortave Acetate
Drug Alias NameAnecortava醋酸阿奈可他AnecortavumRetaaneNSC-24345 +[7] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionVascular endothelial growth factor inhibitors
TargetsVascular endothelial growth factor
Therapy Area/IndicationsInflammationTelangiectasisUveitis, Posterior +[15] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPuerto RicoNetherlands +[9] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAlcon
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAlcon
Active IndicationsN/A
Inactive IndicationsInflammationTelangiectasisUveitis, Posterior +[15] 

Other Information

ATC CodeS01LA02
Related LinksWikipediaDrugBankKEGG